Whereas several publications have proposed a tumor suppressor role for RASA1 in CRC [43–45], we did not observe elevated levels of RAS and ERK activity in RASA1 knock out organoids at basal conditions. This evidence concerns the gene RASA1 and colorectal carcinoma.